Table 1. Quality assessment of human studies on selected criteria.
Criteria | Author(s) (year) | |||||||
---|---|---|---|---|---|---|---|---|
Bramhall et al (2017) 23 | Guest et al (2017) 24 | Liberman et al (2016) 16 | Mehraei et al (2017) 26 | Mehraei et al (2016) 19 | Prendergast et al (2017) 28 | Stuermer et al (2015) 27 | Verhulst et al (2016) 25 | |
Was the paradigm used appropriate for the experimental question(s)? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Did the study account for other possibilities for CS and/or HHL results? | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
Were the experimental conditions assessed unconfounded? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were the dependent variables clearly defined? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were the parameters for measurements described completely? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were measurements made with judges blinded to the experimental conditions? | No | No | No | No | No | No | No | No |
Was interjudge reliability assessed? | No | No | No | No | No | No | No | No |
Was intrajudge reliability assessed? | No | No | No | No | No | No | No | No |
Were “dropouts” accounted for? | Yes | No | No | No | Yes | No | No | No |
Abbreviations: CS, cochlear synaptopathy; HHL, hidden hearing loss.